Table II.
Transdermal Parameters of α-Asarone Patches Prepared by HMPSA Containing Various Penetration Enhancers (n = 3)
| Js/μg·cm−2·h−1 | SD | ER | |
|---|---|---|---|
| NE | 4.80 | 0.89 | – |
| 2% IPM | 6.75 | 1.75 | 1.41 |
| 4% IPM | 7.22 | 1.23 | 1.50 |
| 6% IPM | 4.74 | 0.98 | 0.99 |
| 1% OA | 7.09 | 1.19 | 1.48 |
| 2% OA | 8.20 | 1.01 | 1.71 |
| 5% OA | 6.84 | 1.56 | 1.42 |
| 4% MEN | 8.07 | 1.26 | 1.68 |
| 6% MEN | 6.76 | 1.32 | 1.41 |
| 2% OA + 4% IPM | 6.91 | 0.93 | 1.44 |
| 4% IPM + 4% MEN | 5.30 | 0.82 | 1.10 |
| 4% MEN + 1% OA | 9.62 | 2.20 | 2.00 |
NE no enhancement, OA oleic acid, IPM isopropyl myristate, MEN menthol, Js the flux, SD standard deviation, ER enhancement ratio